Advertisement

European Radiology

, Volume 27, Issue 12, pp 5015–5023 | Cite as

Percutaneous cryoablation of symptomatic venous malformations as a second-line therapeutic option: a five-year single institution experience

  • F. H. Cornelis
  • F. Marin
  • C. Labrèze
  • V. Pinsolle
  • Y. Le Bras
  • D. Midy
  • N. Grenier
Interventional
  • 209 Downloads

Abstract

Purpose

To report the mid-term outcomes of percutaneous cryoablation (PCA) performed as second-line therapeutic option of venous malformations (VM).

Material and methods

From 2011 to 2015, PCA was offered in 24 patients (mean age: 31 years, range: 12–64) as second-line treatment for recurrence of symptoms after sclerotherapy and when resection was not possible (due to lesion location or previous failure) or refused by the patient. Adverse effects were recorded, disease-free survival (DFS) and local tissue control (LTC) rates were calculated based on symptoms and volume evolution.

Results

Mean follow-up was 18.7 months (6–48). Nine (37.5%, 9/24) adverse effects occurred and three (12.5%, 3/24) were severe. Mean pain assessed by visual analog scale (VAS) was 41.7 mm (0–80) before treatment and 20.3 mm (0–80) (p=0.01) after. Mean volume decreased significantly after treatment from 22.4 cm3 (0.9-146) to 8.35 cm3 (0–81.3) (p<0.001). Pain recurred in nine patients and size of one lesion increased. The DFS and LTC rates were 54% [95%CI: 22.94-77.27] and 93.33% [61.26-99.03] at 24 months, respectively. Only VM volume >10 cm3 was associated with a higher risk of local recurrence (p=0.05).

Conclusion

PCA as second-line treatment appears to be safe and effective for local control of VM according to mid-term results.

Key points

• Percutaneous cryoablation of venous malformations appeared well tolerated.

• Size of venous malformations decreased significantly after percutaneous cryoablation (p<0.001).

• Pain decreased significantly after percutaneous cryoablation of venous malformations (p=0.01).

Keywords

Vascular malformation Cryoablation Soft tissue Ultrasound Tolerance 

Notes

Acknowledgements

The authors thank Pippa McKelvie-Sebileau for medical editorial services, Corinne Castermans for her assistance with data collection and Pascal Garcia, PhD for his technical support.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Francois CORNELIS.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Funding

CHU Bordeaux provided partial funding (Grant No. NCT01845935). F.C. received research support from Galil Medical Inc., Arden Hills, MN, USA.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Study subjects or cohorts overlap

Some study subjects or cohorts have been previously reported in "Cornelis F, Havez M, Labrèze C, Taieb A, Bui BN, Midy D, Grenier N. Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol. 2013 Jun;24(6):823–7." and in "Cornelis FH, Labrèze C, Pinsolle V, Le Bras Y, Castermans C, Bader C, Thiebaut R, Midy D, Grenier N. Percutaneous Image-Guided Cryoablation as Second-Line Therapy of Soft-Tissue Venous Vascular Malformations of Extremities: A Prospective Study of Safety and 6-Month Efficacy. Cardiovasc Intervent Radiol. 2017 Mar 30. [Epub ahead of print] "

Methodology

• retrospective

• observational

• performed at one institution

References

  1. 1.
    Mulliken JB (1993) Cutaneous vascular anomalies. Semin Vasc Surg 6:204–218PubMedGoogle Scholar
  2. 2.
    Redondo P, Aguado L, Martinez-Cuesta A (2011) Diagnosis and management of extensive vascular malformations of the lower limb: part II. systemic repercussions [corrected], diagnosis, and treatment. J Am Acad Dermatol 65:909–923, quiz 924CrossRefPubMedGoogle Scholar
  3. 3.
    Redondo P, Aguado L, Martinez-Cuesta A (2011) Diagnosis and management of extensive vascular malformations of the lower limb: part I. clinical diagnosis. J Am Acad Dermatol 65:893–898CrossRefPubMedGoogle Scholar
  4. 4.
    Kim YW (2010) Proper selection of patients for percutaneous embolo-sclerotherapy in patients with congenital vascular malformations (CVMs). Eur J Vasc Endovasc Surg 39:S49–S54CrossRefPubMedGoogle Scholar
  5. 5.
    James CA, Braswell LE, Wright LB et al (2011) Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up. J Vasc Interv Radiol 22:953–960CrossRefPubMedGoogle Scholar
  6. 6.
    Hyodoh H, Hori M, Akiba H et al (2005) Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics 25:S159–S171CrossRefPubMedGoogle Scholar
  7. 7.
    Childs DD, Emory CL (2012) Successful treatment of intramuscular venous malformation with image-guided radiofrequency ablation. J Vasc Interv Radiol 23:1391–1393CrossRefPubMedGoogle Scholar
  8. 8.
    van der Linden E, Overbosch J, Kroft LJ (2005) Radiofrequency ablation for treatment of symptomatic low-flow vascular malformations after previous unsuccessful therapy. J Vasc Interv Radiol 16:747–750CrossRefPubMedGoogle Scholar
  9. 9.
    Garg S, Kumar S, Singh YB (2015) Intralesional radiofrequency in venous malformations. Br J Oral Maxillofac Surg 53:213–216CrossRefPubMedGoogle Scholar
  10. 10.
    Thompson SM, Callstrom MR, McKusick MA, Woodrum DA (2015) Initial results of image-guided percutaneous ablation as second-line treatment for symptomatic vascular anomalies. Cardiovasc Interv Radiol 38:1171–1178CrossRefGoogle Scholar
  11. 11.
    van Breugel JM, Nijenhuis RJ, Ries MG et al (2015) Non-invasive magnetic resonance-guided high intensity focused ultrasound ablation of a vascular malformation in the lower extremity: a case report. J Ther Ultrasound 3:23CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Cornelis F, Havez M, Labrèze C et al (2013) Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol 24:823–827CrossRefPubMedGoogle Scholar
  13. 13.
    Cornelis F, Neuville A, Labreze C et al (2013) Percutaneous cryotherapy of vascular malformation: initial experience. Cardiovasc Interv Radiol 36:853–856CrossRefGoogle Scholar
  14. 14.
    Shaikh R, Alomari AI, Kerr CL, et al. (2016) Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr RadiolGoogle Scholar
  15. 15.
    Cornelis FH, Labrèze C, Pinsolle V, et al. (2017) Percutaneous image-guided cryoablation as second-line therapy of soft-tissue venous vascular malformations of extremities: a prospective study of safety and 6-month efficacy. Cardiovasc Intervent RadiolGoogle Scholar
  16. 16.
    Atwell TD, Farrell MA, Leibovich BC et al (2008) Percutaneous renal cryoablation: experience treating 115 tumors. J Urol 179:2131–2136CrossRefGoogle Scholar
  17. 17.
    Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer 113:2671–2680CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Habash RW, Bansal R, Krewski D, Alhafid HT (2007) Thermal therapy, Part III: ablation techniques. Crit Rev Biomed Eng 35:37–121CrossRefPubMedGoogle Scholar
  19. 19.
    Solomon SB, Silverman SG (2010) Imaging in interventional oncology. Radiology 257:624–640CrossRefPubMedGoogle Scholar
  20. 20.
    Havez M, Lippa N, Al-Ammari S et al (2014) Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Interv Radiol 37:1500–1506CrossRefGoogle Scholar
  21. 21.
    Kujak JL, Liu PT, Johnson GB, Callstrom MR (2010) Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol 39:175–182CrossRefPubMedGoogle Scholar
  22. 22.
    Weld KJ, Landman J (2005) Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumours. BJU Int 96:1224–1229CrossRefPubMedGoogle Scholar
  23. 23.
    Cornelis F, Havez M, Lippa N et al (2013) Radiologically guided percutaneous cryotherapy for soft tissue tumours: a promising treatment. Diagn Interv Imaging 94:364–370CrossRefPubMedGoogle Scholar
  24. 24.
    Tuncali K, Morrison PR, Winalski CS et al (2007) MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol 189:232–239CrossRefPubMedGoogle Scholar
  25. 25.
    Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE (2010) Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254:301–307CrossRefPubMedGoogle Scholar
  26. 26.
    Walder HA (1971) Application of cryotherapy in cerebrovascular anomalies: an experimental and clinical study. J Neurol Neurosurg Psychiatry 34:105CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Yakes WF (2004) Endovascular management of high-flow arteriovenous malformations. Semin Intervent Radiol 21:49–58CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Yakes WF (2015) Use of multiple sclerosant agents in vascular malformation management: a world in endovascular confusion and chaos. J Vasc Interv Radiol 26:1494–1496CrossRefPubMedGoogle Scholar
  29. 29.
    Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 16:S377–S390Google Scholar
  30. 30.
    Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S (1998) Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 34:1381–1389CrossRefPubMedGoogle Scholar
  31. 31.
    Sala F, Niimi Y, Berenstein A, Deletis V (2000) Role of multimodality intraoperative neurophysiological monitoring during embolisation of a spinal cord arteriovenous malformation. Interv Neuroradiol 6:223–234CrossRefPubMedGoogle Scholar
  32. 32.
    van der Vleuten CJ, Kater A, Wijnen MH et al (2014) Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Interv Radiol 37:977–989Google Scholar
  33. 33.
    Behravesh S, Yakes W, Gupta N, et al. (2016) Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther 6:557–569. doi: 10.21037/cdt.2016.11.10Google Scholar
  34. 34.
    McCafferty I (2015) Management of low-flow vascular malformations: clinical presentation, classification, patient selection, imaging and treatment. Cardiovasc Intervent Radiol 38:1082–1104CrossRefPubMedGoogle Scholar
  35. 35.
    Lee BB, Do YS, Byun HS et al (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37:533–538CrossRefPubMedGoogle Scholar
  36. 36.
    Breugem CC, Maas M, Reekers JA, van der Horst CM (2001) Use of magnetic resonance imaging for the evaluation of vascular malformations of the lower extremity. Plast Reconstr Surg 108:870–877CrossRefPubMedGoogle Scholar
  37. 37.
    Breugem CC, Maas M, van der Horst CM (2001) Magnetic resonance imaging findings of vascular malformations of the lower extremity. Plast Reconstr Surg 108:878–884CrossRefPubMedGoogle Scholar
  38. 38.
    Moukaddam H, Pollak J, Haims AH (2009) MRI characteristics and classification of peripheral vascular malformations and tumors. Skelet Radiol 38:535–547CrossRefGoogle Scholar
  39. 39.
    Gokani VJ, Kangesu L, Harper J, Sebire NJ (2011) Venous malformation associated nerve profiles and pain: an immunohistochemical study. J Plast Reconstr Aesthet Surg 64:439–444CrossRefPubMedGoogle Scholar
  40. 40.
    Maillot J, Brun JL, Dubuisson V et al (2017) Mid-term outcomes after percutaneous cryoablation of symptomatic abdominal wall endometriosis: comparison with surgery alone in a single institution. Eur Radiol. doi: 10.1007/s00330-017-4827-7 PubMedGoogle Scholar

Copyright information

© European Society of Radiology 2017

Authors and Affiliations

  • F. H. Cornelis
    • 1
    • 2
  • F. Marin
    • 1
  • C. Labrèze
    • 3
  • V. Pinsolle
    • 4
  • Y. Le Bras
    • 1
  • D. Midy
    • 5
  • N. Grenier
    • 1
  1. 1.Department of RadiologyPellegrin HospitalBordeauxFrance
  2. 2.Department of RadiologyTenon Hospital, APHPParisFrance
  3. 3.Department of Pediatric DermatologyPellegrin HospitalBordeauxFrance
  4. 4.Department of Aesthetic SurgeryPellegrin HospitalBordeauxFrance
  5. 5.Department of Vascular SurgeryPellegrin HospitalBordeauxFrance

Personalised recommendations